Page 2 - Germline Testing News Today

Utilizing real-world evidence that applies to the specific care needs of certain patient populations can promote timely decision-making among payers and providers on the use of effective cancer therapies available on the market, said panelists at the 2022 Patient-Centered Oncology Care® (PCOC) meeting.

/PRNewswire/ -- The "Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact With Executive and...

/PRNewswire/ -- The "Global Genetic Testing Market Forecasts for Applications and Technologies 2021-2025 - COVID-19 Pandemic Impact Updates with Executive and...

ESOU 2021: ESUR Lecture: Genetic Testing for Prostate Cancer: When and How? (UroToday.com) At the 2021 European Association of Urology (EAU) Section of Oncological Urology (ESOU) Virtual Annual Meeting, the EAU Section of Urological Research (ESUR) lecture was provided by Dr. Karen Knudsen discussing when and how to provide genetic testing for prostate cancer. Dr. Knudsen pointed out that there is an extraordinary burden of prostate cancer in the US, ranked as #1 for males in estimated new cas...

News Category Global Banking & Finance Reviews Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing MELBOURNE, Australia, Jan. 21, 2021 — Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on further development on the COVID-...

(2) INDIANAPOLIS (dpa-AFX) - Todays Daily Dose brings you news about the effectiveness of Lillys Bamlanivimab in reducing the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities, executive changes at BiondVax Pharma, regulatory update on Genetic Technologies COVID-19 PRS Test, Adamis SYMJEPI products being made available in the Walgreens Prescription Savings Club, Fluidigms Advanta Dx SARS-CoV-2 RT-PCR Assay receiving the CE-IVD mark. Read on. 1. Adam...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion ... Genetic Technologies LtdJanuary 21, 2021 GMT MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on further development on the COVID-19 serious disease risk P...